Phase II study of MLN8237 (Alisertib) in advanced/ metastatic sarcoma

Mark A. Dickson, M. R. Mahoney, W. D. Tap, S. P. D'Angelo, M. L. Keohan, B. A. Van Tine, M. Agulnik, L. E. Horvath, J. S. Nair, G. K. Schwartz

Research output: Contribution to journalArticlepeer-review

62 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of MLN8237 (Alisertib) in advanced/ metastatic sarcoma'. Together they form a unique fingerprint.

Medicine & Life Sciences